drugset

drugset / Trial / NCT00143143

Pregabalin Open-Label Extension Trial in Patients With Partial Seizures

NCT00143143 ↗

Phase 3 Completed 300 enrolled Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The primary purpose of the protocol is to evaluate the long-term safety of pregabalin in patients with partial seizures.

Timeline

Start: 2001-09
Primary completion: —
Completion: 2006-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pregabalin	Small molecule	—	—

Indications